Not medical advice FMF Companion is an educational synthesis of published literature for study and patient understanding. It does not replace a clinician. Doses and guideline statements are reported as published, not as instructions for any individual.
Familial Mediterranean fever: an animated, cited guide
This page needs JavaScript for its animations. The outline and key answers are below, and every claim in the full version carries a numbered citation.
Not medical advice. FMF Companion is an educational synthesis of published literature. It does not replace a clinician.
What is in it
What FMF is Who gets it, the numbers, and what an attack looks like.
The gene and inheritance MEFV, pyrin, the common variants and an animated Punnett square.
Pyrin, animated How pyrin guards RhoA, and what FMF variants change.
An attack, hour by hour 72 hours of fever, pain, CRP and SAA, site by site.
Colchicine inside the cell From the pill to the neutrophil to the microtubule.
Colchicine over months Why the benefit builds slowly, and what it prevents.
Dosing, safety and interactions What the guidelines and the label publish.
AA amyloidosis Serum amyloid A to fibril to kidney, over years.
Diagnosis and criteria Tel Hashomer, Livneh and the Eurofever/PRINTO calculator.
The differential TRAPS, MKD, CAPS, PFAPA, Behçet and the surgical abdomen.
The treatment ladder Colchicine first, then IL-1 blockade.
Living with FMF Pregnancy, surgery, school, triggers and monitoring.
Toward a cure What a cure would need, and the evidence for each route.
History and people 1908 to the discovery that pyrin senses RhoA.
Flashcards, quiz and glossary Revision for students.
Sources Every reference behind the app.
Part 2 · Colchicine
Colchicine over months
Colchicine is not a painkiller and does not stop an attack that has already started. Its benefit builds as the drug settles into white cells and as weeks pass without the inflammation that would have happened. Drag through two years, then zoom out to decades.
Scenario
Full response, daily doses
Partial response
Many missed doses
Colchicine-resistant
Play Months
Illustrative model. No study has published a week-by-week curve of SAA or attack rate after starting colchicine. The shapes follow what is published: leukocyte pharmacokinetics, response judged over 3–6 months, SAA falling after dose increases, and long-term cohort outcomes. It is not a prediction for any person.
Zoom out: decades and amyloidosis